Jul 31, 2020 7:55 am EDT Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020
Apr 20, 2020 8:30 am EDT Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
Apr 1, 2020 8:30 am EDT Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
Mar 11, 2020 8:00 am EDT Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico